Sponsored By

CBD seeks red-hot status – digital magazineCBD seeks red-hot status – digital magazine

Once a red-hot ingredient, cannabidiol (CBD) seeks to retake the supplement spotlight after a rocky 2020, led by new hemp-derived phytocannabinoids and other derivatives. Market saturation and regulatory uncertainty has hampered industry growth, but research on the endocannabinoid system is connecting CBD intake and various health issues, from inflammation to mood and beyond. Other minor phytocannabinoids identified for more in-depth research include cannabigerol (CBG), cannabinol (CBN) and cannabichromene (CBC).

May 13, 2021

1 Min Read

Takeaways for your business:

• Much remains to be known about the effect of phytocannabinoids on the endocannabinoid system (ECS).
• Cannabinoids with targeted therapeutic promise could drive consumer self-care market expansion.
• Delta-8 THC is on the rise as a psychoactive alternative to THC, and the sports market is watching.


Subscribe and receive the latest insights on the healthy food and beverage industry.
Join 47,000+ members. Yes, it's completely free.

You May Also Like